Certolizumab pegol Active Not Recruiting Phase 3 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01197066Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis